Biote Corp shares are trading lower after the company reported worse-than-expected Q2 EPS results and issued FY23 revenue guidance.
Portfolio Pulse from Benzinga Newsdesk
Biote Corp reported worse-than-expected Q2 EPS results and issued FY23 revenue guidance, causing its shares to trade lower.
August 11, 2023 | 4:11 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biote Corp's worse-than-expected Q2 EPS results and FY23 revenue guidance have led to a decrease in its stock price.
Biote Corp's Q2 EPS results were below expectations, which is generally seen as a negative sign by investors. Additionally, the company's FY23 revenue guidance may have been lower than what investors were hoping for, leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100